The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation (Q35544537)

8 August 2017

title

The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation (English)

1 reference

8 August 2017

main subject

liver transplantation

1 reference

Saskia N de Wildt

0 references

Gideon Koren

1 reference

8 August 2017

Ron H N van Schaik

1 reference

8 August 2017

Offie P Soldin

1 reference

8 August 2017

Steve J Soldin

1 reference

8 August 2017

Parvaneh Yazdani Brojeni

1 reference

8 August 2017

Ilse P van der Heiden

1 reference

8 August 2017

Chris Parshuram

1 reference

8 August 2017

Irena Nulman

1 reference

8 August 2017

language of work or name

1 reference

23 June 2011

1 reference

European Journal of Clinical Pharmacology

8 August 2017

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

1231-1241

1 reference

Pharmacogenetics in immunosuppressants: impact on dose requirement of calcineurin inhibitors in renal and liver pediatric transplant recipients

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

The challenge of achieving target drug concentrations in clinical trials: experience from the Symphony study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Lack of tacrolimus circadian pharmacokinetics and CYP3A5 pharmacogenetics in the early and maintenance stages in Japanese renal transplant recipients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Ontogeny of dextromethorphan O- and N-demethylation in the first year of life

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Buccal vs. nasogastric tube administration of tacrolimus after pediatric liver transplantation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Cytochrome P450 3A4 activity after surgical stress

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Pharmacogenetics and pharmacogenomics.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Pediatric risk of mortality (PRISM) score

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Maturation of dose-corrected tacrolimus predose trough levels in pediatric kidney allograft recipients

27 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Influence of CYP3A5 gene polymorphisms of donor rather than recipient to tacrolimus individual dose requirement in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Effect of CYP3A5 genotype on renal allograft recipients treated with tacrolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Analysis of initial poor graft function after orthotopic liver transplantation: experience of an australian single liver transplantation center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Simultaneous simple and fast quantification of three major immunosuppressants by liquid chromatography--tandem mass-spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Common ATP-binding cassette B1 variants are associated with increased digoxin serum concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Common genetic variation in the ABCB1 gene is associated with the cholesterol-lowering effect of simvastatin in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

MDR1 haplotypes conferring an increased expression of intestinal CYP3A4 rather than MDR1 in female living-donor liver transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Tacrolimus dosing in Chinese renal transplant patients is related to MDR1 gene C3435T polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Effect of age, ethnicity, and glucocorticoid use on tacrolimus pharmacokinetics in pediatric renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Standard dosing of tacrolimus leads to overexposure in pediatric renal transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Efficacy and pharmacokinetics of tacrolimus oral suspension in pediatric liver transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1083-7

Tacrolimus dose requirements and CYP3A5 genotype and the development of calcineurin inhibitor-associated nephrotoxicity in renal allograft recipients

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Initial liver graft function is a reliable predictor of tacrolimus trough levels during the first post-transplant week.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

Optimization of initial tacrolimus dose using pharmacogenetic testing

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3214266

The effect of MDR1 (ABCB1) polymorphism on the pharmacokinetic of tacrolimus in Turkish renal transplant recipients

26 September 2018

1 reference

12 December 2020

Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients

1 reference

12 December 2020

CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of FK 506 in pediatric patients receiving living-related donor liver transplantations

1 reference

12 December 2020

The pharmacokinetics and immunosuppressive response of tacrolimus in paediatric renal transplant recipients

1 reference

12 December 2020

10.1007/S00228-011-1083-7

Identifiers

DOI

1 reference

8 August 2017

1 reference

8 August 2017

1 reference